Yes indeed a very appalling decision from the FDA , they will have to deal with that together with the very serious conflict of interest sooner than you think , while I think the FDA would not have expected this stance from MSB ?I can imagine MSB would have said , sorry we have more pressing and important trials to deal with at this time and that the FDA GVHD decision will have to rest on their heads , its not over yet MSB'ers when the FDA makes a very obvious stupid decision that will kill children with GVHD, heads will roll.
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-391
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.025(2.29%) |
Mkt cap ! $1.216B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.10 | $1.06 | $4.942M | 4.613M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 70659 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 43531 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |